Stefan P. Glaser
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
BCL-XL exerts a protective role against anemia caused by radiation-induced kidney damage.
Journal: The EMBO journal
Published: May 07, 2020
Design, Synthesis, and Biological Activity of 1,2,3-Triazolobenzodiazepine BET Bromodomain Inhibitors.
Journal: ACS medicinal chemistry letters
Published: September 25, 2017
Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1.
Journal: Leukemia
Published: January 29, 2017
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics.
Journal: Cancer cell
Published: September 14, 2016
Rapid Inflammation in Mice Lacking Both SOCS1 and SOCS3 in Hematopoietic Cells.
Journal: PloS one
Published: July 14, 2016
MCL-1 is required throughout B-cell development and its loss sensitizes specific B-cell subsets to inhibition of BCL-2 or BCL-XL.
Journal: Cell death & disease
Published: May 02, 2016
Site-specific recombinatorics: in situ cellular barcoding with the Cre Lox system.
Journal: BMC systems biology
Published: March 08, 2016
Acute myeloid leukemia requires Hhex to enable PRC2-mediated epigenetic repression of Cdkn2a.
Journal: Genes & development
Published: January 06, 2016
Eliminating Legionella by inhibiting BCL-XL to induce macrophage apoptosis.
Journal: Nature microbiology
Published: December 04, 2015
The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia.
Journal: Science translational medicine
Published: August 26, 2015
Last Updated: 09/26/2026